Private equity firm Parthenon Capital has invested in Momentum Life Sciences, a provider of patient support solutions based in Indianapolis. The capital injection aims to fuel Momentum’s growth strategy, which includes pursuing strategic acquisitions. Momentum's existing leadership team will remain significant shareholders post-investment, signaling continuity and commitment.

This partnership provides Momentum with critical strategic resources and capital to expand its reach and capabilities in the patient support sector. The company, led by President and CEO Andi Heslin Smiley, focuses on delivering essential services to patients, a growing area of healthcare delivery. The investment underscores Parthenon Capital's confidence in Momentum's business model and market position.

The deal signifies a significant step for Momentum as it seeks to scale its operations. The infusion of funds will likely enable the company to enhance its service offerings and potentially integrate new technologies or services through acquisitions. This move positions Momentum to capture a larger share of the patient support market.

Momentum Life Sciences will leverage this new backing to solidify its standing and pursue ambitious expansion plans. The Parthenon Capital investment provides the necessary fuel for the company to execute its strategic vision and enhance its impact on patient care delivery.